Ethics of medical research in developing countries: The role of international codes of conduct

Statistical Methods in Medical Research

Volumn 9, Issue 3, 2000, Pages 185-206

  Hutton, J L ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; RETINOL; ZIDOVUDINE;

AFRICA; CLINICAL RESEARCH; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DEVELOPING COUNTRY; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RIGHTS; INCIDENCE; INFORMED CONSENT; MEDICAL ETHICS; MEDICAL RESEARCH; PRACTICE GUIDELINE; PROFESSIONAL STANDARD; RESPONSIBILITY; REVIEW; RISK ASSESSMENT; STATISTICS; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

EID: 0033772865     PISSN: 09622802     EISSN: None     Source Type: Journal    
DOI: 10.1177/096228020000900302     Document Type: Review

References (53)

1. Theories of consent
2. Improving doctors' understanding of statistics
3. The ethics of clinical research in the third world
4. Human rights and maternal-fetal HIV transmission prevention trials in Africa
5. Giving medicine a fair trial
6. Implication of socio-cultural contexts for the ethics of clinical trials
7. Implication of socio-cultural contexts for the ethics of clinical trials
8. The debate over maternal-fetal HIV transmission prevention trials in Africa, Asia, and the Caribbean: Racist exploitation or exploitation of racism?
9. Global disparities in health and human rights: A critical commentary
10. Science, modernity and the 'Final Solution'
11. Proposed revisions to the Declaration of Helsinki - Will they weaken the ethical principles underlying human research?
12. The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials
13. Double standards on informed consent to treatment: Ignored for a quarter of a century by most professional medical ethicists
14. Ethical issues in the design and conduct of cluster randomised controlled trials
15. Ethical issues in the design and conduct of randomised controlled trials
16. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania
17. Clinical trials in 'developing' countries: The fallacy of urgency or ethics vs. economics
18. Human experimentation in historical and ethical perspectives
19. Statistics is essential for professional ethics
20. The ethics of randomised controlled trials: A matter of statistical belief
21. Are distinctive ethical principles required for cluster randomised controlled trials?
22. Some popular versions of uninformed consent
23. Placebo controls in HIV perinatal transmission trials: A South African viewpoint
24. The need to revise the Declaration of Helsinki
25. Ethics of placebo-controlled trials in developing countries
26. Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries
27. The new anti-epileptic drugs: A systematic review of their efficacy and tolerability
28. Are African governments allocating sufficient resources to fight AIDS?
29. The double burden of HIV infection and tuberculosis in sub-saharan africa
30. Revising the Declaration of Helsinki: A fresh start
31. Nuremberg Code (1947)
32. The ethics of HIV research in developing nations
33. Replies to commentaries
34. Is ethical research feasible in developed and developing countries?
35. Unethical perinatal HIV transmission trials establish bad precedent
36. International research ethics
37. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1
38. Mad cows and ecstasy: Chance and choice in an evidence-based society
39. Ethical challenges of HIV clinical trials in developing countries
40. Carbamazepine vs phenobarbitone monotherapy for epilepsy (protocol for a Cochrane Review)
41. Ethical complexities of conducting research in developing countries
42. Informed consent in human experimentation before the Nuremberg code
43. Short course antiretroviral regimens to reduce maternal transmission of HIV
44. Statistical review by research ethics committees
45. Challenges to human subject protections in US medical research
46. Declaration of Helsinki (1964, 1975, 1983, 1989, 1996, currently under review)